XML 67 R53.htm IDEA: XBRL DOCUMENT v3.22.2
Share-Based Compensation - Summary of the Option Unit Activity (Details)
$ / shares in Units, $ in Millions
6 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Expected weighted average period 3 years 4 months 24 days
2021 Equity Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 3,714,540
Number of units, granted | shares 496,627
Number of grants, forfeited | shares (8,800)
Number of units, grant outstanding ending balance | shares 4,202,367
Number of grants, vested | shares 999,352
Number of grants, unvested | shares 3,203,015
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 15.33
Weighted average exercise price, exercised | $ / shares 14.82
Weighted average exercise price, forefeited | $ / shares 17.52
Weighted average exercise price, grant outstanding ending balance | $ / shares 15.27
Weighted average exercise price, grants vested | $ / shares 15.07
Weighted average exercise price, grants unvested | $ / shares $ 15.33
Weighted Average Remaining Contractual Term, grants outstanding 9 years 1 month 6 days
Expected weighted average period 9 years
Aggregate Intrinsic Value, grants outstanding | $ $ 0.0
Aggregate Intrinsic Value, grants vested | $ $ 0.0
First Advantage Corporation [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 3,519,563
Number of grants, exercised | shares (192,230)
Number of grants, forfeited | shares (113,264)
Number of units, grant outstanding ending balance | shares 3,214,069
Number of grants, vested | shares 820,282
Number of grants, unvested | shares 2,393,787
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 6.66
Weighted average exercise price, exercised | $ / shares 6.67
Weighted average exercise price, forefeited | $ / shares 6.61
Weighted average exercise price, grant outstanding ending balance | $ / shares 6.66
Weighted average exercise price, grants vested | $ / shares 6.64
Weighted average exercise price, grants unvested | $ / shares $ 6.67
Weighted Average Remaining Contractual Term, grants outstanding 7 years 8 months 12 days
Expected weighted average period 7 years 8 months 12 days
Aggregate Intrinsic Value, grants outstanding | $ $ 19.3
Aggregate Intrinsic Value, grants vested | $ $ 4.9